anti-wrinkle
Botox, Jeauveau, Xeomin
“Fountain of youth” in a vial
Wrinkling is a prominent feature of skin aging. Skin naturally thins, loses volume over time as dermal collagen, hyaluronic acid and elastin gradually diminishes. With sun exposure and smoking dermal atrophy is also accelerated.
However, there is a way to slow down skin ageing and turn back time!
Frequently Asked Questions
What is Botox, Jeauveau & Xeomin?
FDA approved neuromodulators that temporarily reduce muscle contraction by inhibiting acetylcholine release at the neuromuscular junction. When muscle movement is minimized, it helps smooth out the lines and wrinkles on your face and gives you a refreshed look.
​
Is botulinum toxin treatment painful? Do I need anesthesia?
Anesthesia is typically not required. If necessary, ice or a topical anesthetic may be used before injections (benzocaine, lidocaine, tetracaine) for 15 – 20 minutes prior to treatment. Please make your provider to be aware for a request of anesthesia. In this case, you will need to arrive 20 minutes earlier for treatment preparation.
​
Are there any specific preparations before Botox, Jeauveau & Xeomin treatment?
If possible, stop temporarily using NSAIDs 5 days prior to your appointment and reduce alcohol intake to decrease bleeding and bruising formation.
​
Any possible side effects or complications after the injections?
The symptoms may include localized burning or stinging pain during injection, bruising, infection, generalized muscle weakness, double vision, dry eye, incomplete eyelid closure, blurred vision, eyelid droop, droopy eyebrows, worsening eye bags, smile, and asymmetry.
​
What are the contraindications?
Unrealistic expectations or body dysmorphic disorder.
​
Neuromuscular disorders such as amyotrophic lateral sclerosis, myasthenia gravis, and myopathies.
Pregnancy or nursing.
​
Skin atrophy (chronic oral steroid use, genetic syndromes such as Ehlers-Danlos syndrome).
​
Active psoriasis, and eczema in the treatment area.
​
Sensitivity or allergy to constituents of botulinum toxin (including botulinum toxin serotype A, human albumin, lactose, or sodium succinate).
​
Bleeding abnormality and anticoagulant use.
Immunosuppression.
Weakness in the treatment area due to polio, Bell’s palsy.
Active infection in the treatment area (herpes simplex, postural acne, cellulitis).
​
Ocular surgery within six months.
​
​